3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Drug-Related Side Effects and Adverse Reactions
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
acalabrutinib
2
Social Determinants of Health
2
Electrocardiography
2
Echocardiography
2
Blood Specimen Collection
2
Aspirin
2
Antineoplastic Agents
2
zanubrutinib
1
ribociclib
1
phosphoribosylformylglycinamidine synthetase
1
palbociclib
1
ibrutinib
1
glycidol
1
abemaciclib
1
Vascular Stiffness
1
Testosterone
1
Pulse Wave Analysis
1
Noninvasive Prenatal Testing
1
Magnetic Resonance Spectroscopy
1
Health Services Needs and Demand
1
Gonadotropin-Releasing Hormone
1
Genetic Testing
1
Exercise
1
Eating
1
Diet
1
DNA
1
Chemoradiotherapy
1
Cardiovascular Agents
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Cardiovascular Diseases
×
Social Determinants of Health
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT05078190
2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled